Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

86 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design.
Suker J, Feavers IM, Maiden MC. Suker J, et al. Among authors: feavers im. Microbiology (Reading). 1996 Jan;142 ( Pt 1):63-9. doi: 10.1099/13500872-142-1-63. Microbiology (Reading). 1996. PMID: 8581171
Whole-cell pertussis vaccine potency assays: the Kendrick test and alternative assays.
Xing D, Markey K, Das RG, Feavers I. Xing D, et al. Expert Rev Vaccines. 2014 Oct;13(10):1175-82. doi: 10.1586/14760584.2014.939636. Epub 2014 Sep 3. Expert Rev Vaccines. 2014. PMID: 25182836 Review.
Adjuvant effects on antibody titre.
Walker B, Feavers I. Walker B, et al. Methods Mol Biol. 2010;626:187-98. doi: 10.1007/978-1-60761-585-9_13. Methods Mol Biol. 2010. PMID: 20099129
Functional antibody assays.
Feavers I, Walker B. Feavers I, et al. Methods Mol Biol. 2010;626:199-211. doi: 10.1007/978-1-60761-585-9_14. Methods Mol Biol. 2010. PMID: 20099130
WHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3-4 October 2011.
Feavers I, Griffiths E, Baca-Estrada M, Knezevic I, Zhou T. Feavers I, et al. Biologicals. 2012 Nov;40(6):507-16. doi: 10.1016/j.biologicals.2012.09.008. Epub 2012 Oct 16. Biologicals. 2012. PMID: 23078946
Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.
Sadarangani M, Hoe JC, Callaghan MJ, Jones C, Chan H, Makepeace K, Daniels-Treffandier H, Deadman ME, Bayliss C, Feavers I, van der Ley P, Pollard AJ. Sadarangani M, et al. PLoS One. 2012;7(12):e51045. doi: 10.1371/journal.pone.0051045. Epub 2012 Dec 12. PLoS One. 2012. PMID: 23251421 Free PMC article.
Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Finney M, Vaughan T, Taylor S, Hudson MJ, Pratt C, Wheeler JX, Vipond C, Feavers I, Jones C, Findlow J, Borrow R, Gorringe A. Finney M, et al. Hum Vaccin. 2008 Jan-Feb;4(1):23-30. doi: 10.4161/hv.4.1.4806. Epub 2007 Jul 29. Hum Vaccin. 2008. PMID: 17921703
An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity.
Norheim G, Sanders H, Mellesdal JW, Sundfør I, Chan H, Brehony C, Vipond C, Dold C, Care R, Saleem M, Maiden MC, Derrick JP, Feavers I, Pollard AJ. Norheim G, et al. PLoS One. 2015 Sep 21;10(9):e0134353. doi: 10.1371/journal.pone.0134353. eCollection 2015. PLoS One. 2015. PMID: 26390123 Free PMC article.
Investigation into the Antigenic Properties and Contributions to Growth in Blood of the Meningococcal Haemoglobin Receptors, HpuAB and HmbR.
Bidmos FA, Chan H, Praekelt U, Tauseef I, Ali YM, Kaczmarski EB, Feavers I, Bayliss CD. Bidmos FA, et al. PLoS One. 2015 Jul 24;10(7):e0133855. doi: 10.1371/journal.pone.0133855. eCollection 2015. PLoS One. 2015. PMID: 26208277 Free PMC article.
Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.
Mehta OH, Norheim G, Hoe JC, Rollier CS, Nagaputra JC, Makepeace K, Saleem M, Chan H, Ferguson DJ, Jones C, Sadarangani M, Hood DW, Feavers I, Derrick JP, Pollard AJ, Moxon ER. Mehta OH, et al. PLoS One. 2014 Dec 29;9(12):e115713. doi: 10.1371/journal.pone.0115713. eCollection 2014. PLoS One. 2014. PMID: 25545241 Free PMC article.
86 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback